866-997-4948(US-Canada Toll Free)

Seasonal Influenza Vaccine Market in Asia - Pacific Region - Threat of Pandemic Influenza and Increasing Vaccination Coverage to Drive Growth

Published By :

GBI Research

Published Date : Jan 2011

Category :

Therapeutic Area

No. of Pages : 114 Pages


GBI Research, the leading business intelligence provider has released its latest research “Seasonal Influenza Vaccine Market in Asia-Pacific Region-Threat of Pandemic Influenza and Increasing Vaccination Coverage to Drive Growth” which essentially provides insights on seasonal influenza vaccine sales forecasts for the Asia-Pacific Region until 2016. 

The report also delves deep into vaccination patterns for seasonal influenza in the Asia-Pacific Region. Further, the geographical distribution of seasonal influenza vaccines across Australia, New Zealand, Taiwan, Philippines, Hong Kong and Singapore are also provided in the report. The report offers a clear view of the regulatory landscape in the Asia-Pacific countries. 

The report also includes insights into the seasonal influenza vaccine R&D pipeline and offers profiles of promising vaccines. The report explores the competitive landscape including profiles for top companies. Finally, the key trend analysis on mergers and acquisitions, and licensing agreements involving seasonal influenza vaccines is also presented.

Scope

The scope of this report includes:

  • Data and analysis on the seasonal influenza vaccine market in the Asia-Pacific Region including Australia, New Zealand, Taiwan, Philippines, Malaysia, Hong Kong and Singapore.
  • Market forecasts for the seasonal influenza vaccines until 2016
  • Market Data on geographical landscape including country wise vaccination coverage, public and private contribution on total doses, price of vaccine, market size and market share.
  • Key drivers and restraints that have created significant impact on the market.
  • Regulatory landscape including the pharmaceutical product approval process and overview of regulatory authorities in the countries in Asia-Pacific region
  • Competitive landscape of the seasonal influenza vaccine market in Asia-Pacific region including top companies profiles. The key companies studied in this report are Sanofi Pasteur, Abbott Laboratories, GlaxoSmithKline Biologicals, Novartis Vaccines, CSL Biotherapies, AdImmune and Crucell.
  • Key M&A activities, Licensing Agreements, that have taken place between 2007 and 2010 in the seasonal influenza vaccine market.

Reasons to buy

The report will aid business development and marketing executives strategizing their product launches:

  • Build effective strategies to launch their pipeline products by identifying potential geographies.
  • Exploit in-licensing and out-licensing opportunities by identifying products that might probably fill their portfolio gaps.
  • Develop key strategic initiatives by studying the key strategies of top competitors.
  • Develop market-entry and market expansion strategies by identifying the geographic markets poised for strong growth.
  • Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class vaccines with more efficacy and better safety.
Table of Contents

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Seasonal Influenza Vaccine Market in Asia-Pacific Region: Introduction
2.1 Influenza
2.2 GBI Research Report Guidance

3 Seasonal Influenza Vaccine Market in Asia-Pacific Region: Market Overview
3.1 Production Cycle for the Seasonal Influenza Vaccines
3.2 The Asia-Pacific Region Seasonal Influenza Vaccine Market
3.3 Revenue Forecasts for the Seasonal Influenza Vaccine Market
3.4 Geographical Segmentation

4 Seasonal Influenza Vaccine Market in Asia-Pacific Region: Geographical Landscape

4.1 Revenue Analysis by Geography
4.2 Australia
4.2.1 Vaccination Pattern
4.2.2 Cost of Vaccine
4.2.3 Total Revenue
4.3 New Zealand
4.3.1 Vaccination Pattern
4.3.2 Cost of Vaccine
4.3.3 Total Revenue
4.3.4 Major Players by Market Share
4.4 Taiwan
4.4.1 Vaccination Pattern
4.4.2 Cost of Vaccine
4.4.3 Total Revenue
4.4.4 Major Players by Market Share
4.5 Philippines
4.5.1 Vaccination Pattern
4.5.2 Cost of Vaccine
4.5.3 Total Revenue
4.5.4 Major Players by Market Share
4.6 Malaysia
4.6.1 Vaccination Pattern
4.6.2 Cost of Vaccine
4.6.3 Total Revenue
4.6.4 Major Players by Market Share
4.7 Hong Kong
4.7.1 Vaccination Pattern
4.7.2 Cost of Vaccine
4.7.3 Total Revenue
4.7.4 Major Players by Market Share
4.8 Singapore
4.8.1 Vaccination Pattern
4.8.2 Cost of Vaccine
4.8.3 Total Revenue
4.8.4 Major Players by Market Share

5 Seasonal Influenza Vaccine Market in Asia-Pacific Region: Drivers and Restraints

5.1 Drivers for the Seasonal Influenza Vaccine Market in the Asia-Pacific Region
5.1.1 Threat of Pandemic Influenza
5.1.2 Increasing Vaccination Coverage for Seasonal Influenza Vaccines
5.1.3 Emergence of Novel Production Technologies and Vaccines
5.1.4 Population Growth
5.1.5 Economic Reasons
5.2 Restraints for the Seasonal Influenza Vaccine Market in the Asia-Pacific Region
5.2.1 Entry Barriers in the Seasonal Influenza Vaccine Market
5.2.2 Variable Demand
5.2.3 Limited Production Capacity
5.3 Australia
5.3.1 Drivers
5.3.2 Restraints
5.4 New Zealand
5.4.1 Drivers
5.4.2 Restraints
5.5 Taiwan
5.5.1 Drivers
5.5.2 Restraints
5.6 Philippines
5.6.1 Drivers
5.6.2 Restraints
5.7 Malaysia
5.7.1 Drivers
5.7.2 Restraints
5.8 Hong Kong
5.8.1 Drivers
5.8.2 Restraints
5.9 Singapore
5.9.1 Drivers
5.9.2 Restraints

6 Seasonal Influenza Vaccine Market in Asia-Pacific Region: Regulatory Landscape
6.1 Registration Process and Regulations in Australia
6.2 Registration Process and Regulations in New Zealand
6.3 Registration Process and Regulations in Taiwan
6.4 Registration Process and Regulations in the Philippines
6.5 Registration Process and Regulations in Malaysia
6.6 Registration Process and Regulations in Hong Kong
6.7 Registration Process and Regulations in Singapore

7 Seasonal Influenza Vaccine Market in Asia-Pacific Region: Pipeline Analysis
7.1 Seasonal Influenza Vaccines - Promising Vaccines under Clinical Development
7.2 Profiles for Promising Vaccines under Clinical Development
7.2.1 Optaflu
7.2.2 GSK2186877A
7.2.3 Intanza / Flu-ID
7.2.4 Fluad Pediatric
7.3 Research and Development Pipeline

8 Seasonal Influenza Vaccine Market in Asia-Pacific Region: Competitive Landscape

8.1 Major Seasonal Influenza Vaccines Marketed in the APAC Region
8.1.1 Fluarix
8.1.2 Vaxigrip
8.1.3 Influvac
8.1.4 Fluvax
8.1.5 Agrippal
8.2 Key Areas Focused for R&D
8.3 Competitive Profiling
8.3.1 Sanofi Pasteur
8.3.2 GlaxoSmithKline Biologicals
8.3.3 Abbott Laboratories (Solvay Pharmaceuticals)
8.3.4 CSL Biotherapies
8.3.5 Novartis Vaccines
8.3.6 Adimmune Corporation
8.3.7 Crucell N.V. (Berna Biotech)

9 Seasonal Influenza Vaccine Market in Asia-Pacific Region: M&A Landscape
9.1 Overview
9.1.1 AstraZeneca Acquires Medimmune
9.1.2 Sanofi Aventis Acquires Acambis
9.1.3 Mymetics Acquires Virosome Biologicals
9.1.4 Simcere Pharmaceutical Acquires a Majority Stake in Jiangsu Yanshen Biological Technology Stock
9.1.5 Novartis to Acquire a Majority Stake in Zhejiang Tianyuan
9.1.6 Abbott Laboratories Acquires Solvay Pharmaceuticals
9.1.7 Nutri Pharma Acquires a Majority Stake in Bionor Immuno
9.1.8 Johnson & Johnson to Acquire a Majority Stake in Crucell
9.2 M&A Deals by Value
9.3 M&A Deals by Geography
9.4 R&D Licensing Agreements for the Period 2007-2010
9.4.1 Crucell Enters Into License Agreement With ADImmune
9.4.2 MedImmune Enters Into Licensing Agreement With Sanofi Pasteur
9.4.3 Vivalis Enters Into Licensing Agreement With GlaxoSmithKline
9.4.4 Vivalis Enters Into Licensing Agreement With Nobilon International
9.4.5 MedImmune Enters Into Licensing Agreement With GlaxoSmithKline
9.4.6 Hemispherx Biopharma Enters Into Licensing Agreement With BIKEN
9.4.7 MedImmune Enters Into Licensing Agreement With BIKEN
9.4.8 MedImmune Enters Into Licensing Agreement With Omninvest
9.4.9 OPKO Health Enters Into Licensing Agreement With Academia Sinica
9.4.10 AltraVax Enters Into Licensing Agreement With Maxygen
9.4.11 NasVax Announces Option Licensing Agreement With Novartis
9.4.12 iBio Enters Into Licensing Agreement With G-Con
9.4.13 Deals by Geography

10 Seasonal Influenza Vaccine Market in Asia-Pacific Region: Appendix
10.1 Market Definitions
10.2 Abbreviations
10.3 Research Methodology
10.3.1 Coverage
10.3.2 Secondary Research
10.3.3 Primary Research
10.3.4 Expert Panel Validation
10.4 Contact Us
10.5 Disclaimer
10.6 Sources

List of Table


Table 1: Seasonal Influenza Vaccine Market, APAC Region, Revenue ($m), 2009-2016 14
Table 2: Seasonal Influenza Vaccine Market, APAC Region, Country Wise Revenue ($m), 2009-2016 15
Table 3: Seasonal Influenza Vaccine Market, Australia, Vaccinated Population Contribution by Age Groups (%), 2009-2016 19
Table 4: Seasonal Influenza Vaccine Market, Australia, Overall Vaccination Coverage (Thousands), 2009-2016 19
Table 5: Seasonal Influenza Vaccine Market, Australia, Vaccination Coverage Break-up by Age Groups (Thousand), 2009-2016 19
Table 6: Seasonal Influenza Vaccine Market, Australia, Overall Number of Doses (Thousands), 2009-2016 20
Table 7: Seasonal Influenza Vaccine Market, Australia, Number of Doses by Age Groups, (Thousands), 2009-2016 21
Table 8: Seasonal Influenza Vaccine Market, Australia, Revenue ($m), 2009-2016 22
Table 9: Seasonal Influenza Vaccine Market, New Zealand, Vaccinated Population Contribution by Age Groups (%), 2009-2016 25
Table 10: Seasonal Influenza Vaccine Market, New Zealand, Overall Vaccination Coverage (Thousands), 2009-2016 26
Table 11: Seasonal Influenza Vaccine Market, New Zealand, Vaccination Coverage by Age Groups (Thousands), 2009-2016 26
Table 12: Seasonal Influenza Vaccine Market, New Zealand, Overall Number of Doses (Thousands), 2009-2016 26
Table 13: Seasonal Influenza Vaccine Market, New Zealand, Number of Doses by Age Groups (Thousands), 2009-2016 27
Table 14: Seasonal Influenza Vaccine Market, New Zealand, Revenues ($000s), 2009-2016 28
Table 15: Seasonal Influenza Vaccine Market, Taiwan, Vaccinated Population Contribution by Age Groups (%), 2009-2016 32
Table 16: Seasonal Influenza Vaccine Market, Taiwan, Overall Vaccination Coverage (Thousands), 2009-2016 33
Table 17: Seasonal Influenza Vaccine Market, Taiwan, Vaccination Coverage by Age Groups (Thousands), 2009-2016 33
Table 18: Seasonal Influenza Vaccine Market, Taiwan, Overall Number of Doses (Thousands), 2009-2016 33
Table 19: Seasonal Influenza Vaccine Market, Taiwan, Number of Doses by Age Groups (Thousands), 2009-2016 34
Table 20: Seasonal Influenza Vaccine Market, Taiwan, Revenues ($m), 2009-2016 36
Table 21: Seasonal Influenza Vaccine Market, Philippines, Vaccinated Population Contribution by Age Groups (%), 2009-2016 39
Table 22: Seasonal Influenza Vaccine Market, Philippines, Overall Vaccination Coverage (Thousands), 2009-2016 40
Table 23: Seasonal Influenza Vaccine Market, Philippines, Vaccination Coverage by Age Groups (Thousands), 2009-2016 40
Table 24: Seasonal Influenza Vaccine Market, Philippines, Overall Number of Doses (Thousands), 2009-2016 40
Table 25: Seasonal Influenza Vaccine Market, Philippines, Number of Doses by Age Groups (Thousands), 2009-2016 41
Table 26: Seasonal Influenza Vaccine Market, Philippines, Revenues ($m), 2009-2016 43
Table 27: Seasonal Influenza Vaccine Market, Malaysia, Vaccinated Population Contribution by Age Groups (%), 2009-2016 46
Table 28: Seasonal Influenza Vaccine Market, Malaysia, Overall Vaccination Coverage (Thousands), 2009-2016 47
Table 29: Seasonal Influenza Vaccine Market, Malaysia, Vaccination Coverage by Age Groups (Thousands), 2009-2016 47
Table 30: Seasonal Influenza Vaccine Market, Malaysia, Overall Number of Doses (Thousands), 2009-2016 47
Table 31: Seasonal Influenza Vaccine Market, Malaysia, Number of Doses by Age Groups (Thousands), 2009-2016 48
Table 32: Seasonal Influenza Vaccine Market, Malaysia, Revenues ($m), 2009-2016 49
Table 33: Seasonal Influenza Vaccine Market, Hong Kong, Vaccinated Population Contribution by Age Groups (%), 2009-2016 53
Table 34: Seasonal Influenza Vaccine Market, Hong Kong, Overall Vaccination Coverage (Thousands), 2009-2016 54
Table 35: Seasonal Influenza Vaccine Market, Hong Kong, Vaccination Coverage by Age Groups (Thousands), 2009-2016 54
Table 36: Seasonal Influenza Vaccine Market, Hong Kong, Overall Number of Doses (Thousands), 2009-2016 54
Table 37: Seasonal Influenza Vaccine Market, Hong Kong, Number of Doses by Age Groups (Thousands), 2009-2016 55
Table 38: Seasonal Influenza Vaccine Market, Hong Kong, Revenues ($m), 2009-2016 56
Table 39: Seasonal Influenza Vaccine Market, Singapore, Vaccinated Population Contribution by Age Groups (%), 2009-2016 60
Table 40: Seasonal Influenza Vaccine Market, Singapore, Overall Vaccination Coverage (Thousands), 2009-2016 61
Table 41: Seasonal Influenza Vaccine Market, Singapore, Vaccination Coverage by Age Groups (Thousands), 2009-2016 61
Table 42: Seasonal Influenza Vaccine Market, Singapore, Overall Number of Doses (Thousands), 2009-2016 61
Table 43: Seasonal Influenza Vaccine Market, Singapore, Number of Doses by Age Groups (Thousands), 2009-2016 62
Table 44: Seasonal Influenza Vaccine Market, Singapore, Revenues ($m), 2009-2016 63
Table 45: Seasonal Influenza Vaccine Market, Most Promising Vaccines Under Clinical Development, 2010 92
Table 46: Seasonal Influenza Vaccine Market, Asia-Pacific Region, Pipeline, Filed in the US, 2010 97
Table 47: Seasonal Influenza Vaccines, Asia-Pacific Region, Phase III Clinical Pipeline, 2010 98
Table 48: Seasonal Influenza Vaccines, Asia-Pacific Region, Phase II Clinical Pipeline, 2010 98
Table 49: Seasonal Influenza Vaccines, Asia-Pacific Region, Phase I Clinical Pipeline, 2010 99
Table 50: Seasonal Influenza Vaccines, Asia-Pacific Region, Pre-Clinical Pipeline, 2010 99
Table 51: Seasonal Influenza Vaccines, Asia-Pacific Region, Discovery Phase Pipeline 100
Table 52: Seasonal Influenza Vaccine Market, Asia-Pacific, Major M&A Deals, 2007-2010 105

List of Chart


Figure 1: Seasonal Influenza Vaccine Market, APAC Region, Revenue ($m), 2009-2016 14
Figure 2: Seasonal Influenza Vaccine Market, APAC Region, Country Wise Market Share (%), 2009 and 2016 15
Figure 3: Seasonal Influenza Vaccine Market, Australia, Population (Thousands), 2009-2016 17
Figure 4: Seasonal Influenza Vaccine Market, Australia, Vaccinated Population Contribution by Age Groups (%), 2009-2016 18
Figure 5: Seasonal Influenza Vaccine Market, Australia, Number of Doses by Age Groups, (Thousands), 2009-2016 20
Figure 6: Seasonal Influenza Vaccine Market, Australia, Revenue ($m), 2009-2016 22
Figure 7: Seasonal Influenza Vaccine Market, Australia, Break-up of Revenues ($m), 2009-2016 23
Figure 8: Seasonal Influenza Vaccine Market, New Zealand, Population (Thousands), 2009-2016 24
Figure 9: Seasonal Influenza Vaccine Market, New Zealand, Vaccinated Population Contribution by Age Groups (%), 2009-2016 25
Figure 10: Seasonal Influenza Vaccine Market, New Zealand, Number of Doses by Age Groups (Thousands), 2009-2016 27
Figure 11: Seasonal Influenza Vaccine Market, New Zealand, Revenues ($m), 2009-2016 28
Figure 12: Seasonal Influenza Vaccine Market, New Zealand, Break-up of Revenues ($m), 2009-2016 29
Figure 13: Seasonal Influenza Vaccine Market, New Zealand, Market Share for Top Manufacturers, (%), 2009 30
Figure 14: Seasonal Influenza Vaccine Market, Taiwan, Population (Thousands), 2009-2016 31
Figure 15: Seasonal Influenza Vaccine Market, Taiwan, Vaccinated Population Contribution by Age Groups (%), 2009-2016 32
Figure 16: Seasonal Influenza Vaccine Market, Taiwan, Number of Doses by Age Groups (Thousands), 2009-2016 34
Figure 17: Seasonal Influenza Vaccine Market, Taiwan, Revenues ($m), 2009-2016 35
Figure 18: Seasonal Influenza Vaccine Market, Taiwan, Break-up of Revenues ($m), 2009-2016 36
Figure 19: Seasonal Influenza Vaccine Market, Taiwan, Market Share for Top Manufacturers, (%), 2009 37
Figure 20: Seasonal Influenza Vaccine Market, Philippines, Population (Thousands), 2009-2016 38
Figure 21: Seasonal Influenza Vaccine Market, Philippines, Vaccinated Population Contribution by Age Groups (%), 2009-2016 39
Figure 22: Seasonal Influenza Vaccine Market, Philippines, Number of Doses by Age Groups (Thousands), 2009-2016 41
Figure 23: Seasonal Influenza Vaccine Market, Philippines, Revenues ($m), 2009-2016 42
Figure 24: Seasonal Influenza Vaccine Market, Philippines, Break-up of Revenues ($m), 2009-2016 43
Figure 25: Seasonal Influenza Vaccine Market, Philippines, Market Share for Top Manufacturers, (%), 2009 44
Figure 26: Seasonal Influenza Vaccine Market, Malaysia, Population (Thousands), 2009-2016 45
Figure 27: Seasonal Influenza Vaccine Market, Malaysia, Vaccinated Population Contribution by Age Groups (%), 2009-2016 46
Figure 28: Seasonal Influenza Vaccine Market, Malaysia, Number of Doses by Age Groups (Thousands), 2009-2016 48
Figure 29: Seasonal Influenza Vaccine Market, Malaysia, Revenues ($m), 2009-2016 49
Figure 30: Seasonal Influenza Vaccine Market, Malaysia, Break-up of Revenues ($m), 2009-2016 50
Figure 31: Seasonal Influenza Vaccine Market, Malaysia, Market Share for Top Manufacturers, (%), 2009 51
Figure 32: Seasonal Influenza Vaccine Market, Hong Kong, Population (Thousands), 2009-2016 52
Figure 33: Seasonal Influenza Vaccine Market, Hong Kong, Vaccinated Population Contribution by Age Groups (%), 2009-2016 53
Figure 34: Seasonal Influenza Vaccine Market, Hong Kong, Number of Doses by Age Groups (Thousands), 2009-2016 55
Figure 35: Seasonal Influenza Vaccine Market, Hong Kong, Revenues ($m), 2009-2016 56
Figure 36: Seasonal Influenza Vaccine Market, Hong Kong, Break-up of Revenues ($m), 2009-2016 57
Figure 37: Seasonal Influenza Vaccine Market, Hong Kong, Market Share for Top Manufacturers, (%), 2009 58
Figure 38: Seasonal Influenza Vaccine Market, Singapore, Population (Thousands), 2009-2016 59
Figure 39: Seasonal Influenza Vaccine Market, Singapore, Vaccinated Population Contribution by Age Groups (%), 2009-2016 60
Figure 40: Seasonal Influenza Vaccine Market, Singapore, Number of Doses by Age Groups (Thousands), 2009-2016 62
Figure 41: Seasonal Influenza Vaccine Market, Singapore, Revenues ($m), 2009-2016 63
Figure 42: Seasonal Influenza Vaccine Market, Singapore, Break-up of Revenues ($m), 2009-2016 64
Figure 43: Seasonal Influenza Vaccine Market, Singapore, Market Share for Top Manufacturers, (%), 2009 65
Figure 44: Seasonal Influenza Vaccine Market, APAC Region, Drivers and Restraints, 2009-2016 66
Figure 45: Total Detections of Influenza Virus in APAC Countries during 2000-2010 67
Figure 46: Increase in Influenza Cases Due to H1N1 Pandemic Influenza in 2009 68
Figure 47: Increasing Vaccination Coverage Against Seasonal Influenza 69
Figure 48: Vaccination Coverage Rates Forecasts for APAC Region, (%), 2009-2016 70
Figure 49: Regulatory Authorities in Australia 77
Figure 50: Drug Approval Process in Australia 78
Figure 51: Regulatory Authorities in New Zealand 79
Figure 52: Drug Approval Process in New Zealand 80
Figure 53: Regulatory Authorities in Taiwan 83
Figure 54: Drug Approval Process in Taiwan 84
Figure 55: Regulatory Authorities in the Philippines 85
Figure 56: Drug Approval Process in Philippines 85
Figure 57: Regulatory Authorities in Malaysia 87
Figure 58: Drug Approval Process in Malaysia 88
Figure 59: Regulatory Authorities in Hong Kong 89
Figure 60: Drug Approval Process in Hong Kong 89
Figure 61: Regulatory Authorities in Singapore 90
Figure 62: Drug Approval Process in Singapore 90
Figure 63: Seasonal Influenza Vaccine Market, Asia-Pacific Region, R&D Pipeline by Phase (%), 2010 96
Figure 64: Seasonal Influenza Vaccine Market, Asia-Pacific Region, Clinical Pipeline by Class of Vaccine (%), 2010 97
Figure 65: Seasonal Influenza Vaccine Market, Product Pipeline of Major Players in Asia-Pacific Region, 2010 102
Figure 66: Seasonal Influenza Vaccine Market, M&A Deals by Value, (%), 2007-2010 107
Figure 67: Seasonal Influenza Vaccine Market, M&A Deals by Geography, (%), 2007-2010 108
Figure 68: Seasonal Influenza Vaccine Market, Major R&D and Licensing Agreements by Geography, (%), 2007-2010 111

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *